Yonsei Med J.  1997 Dec;38(6):411-422. 10.3349/ymj.1997.38.6.411.

Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe

Affiliations
  • 1German Registry of Adamantiades-Behcet's Disease, Department of Dermatology, University Medical Center Benjamin Franklin, Free University of Berlin, Germany. zoubbere@zedat.fu-berlin.de
  • 2Department of Internal Medicine II, University Medical Center, Eberhard Karls University of T bingen.
  • 3Department of Dermatology, State Hospital of Heilbronn.
  • 4Department of Clinical Pharmacology, Technical University of Dresden.
  • 5Department of Internal Medicine, University Medical Center, Christian Albrecht University of Kiel.
  • 6Department of Dermatology and Venereology, Academic Hospital of Neuk lln, Berlin.
  • 7Department of Dermatology, University Medical Center, Ruprecht Karls University of Heidelberg.
  • 8Department of Dermatology, University Medical Center, Johann Wolfgan Goethe University of Frankfurt am Main.
  • 9Department of Rheumatology, State Hospital of Vogelsang.
  • 10Department of Dermatology, Hospital of Minden.
  • 11Department of Dermatology, University Medical Center, Friedrich Schiller University of Jena.
  • 12Department of Dermatology, University Medical Center, Christian Albrecht University of Kiel.
  • 13Dermatologist, Burscheid.
  • 14Municipal Hospital of Nauen, Staaken.
  • 15Department of Dermatology and Venereology, Medical Faculty, Otto von Guericke University of Magdeburg.
  • 16Department of Dermatology and Allergology, City Hospital of Oldenburg.
  • 17Dermatologist, Landau.
  • 18Department of Internal Medicine, University of Ulm, Germany.

Abstract

The German Registry of Adamantiades-Behcet's disease was founded in 1990 in Berlin and it provides current data on the epidemiology, the clinical manifestations and the course of the disease in Germany on a continuous basis. A total of 218 patients, including 89 German and 100 Turkish patients, had been reported to the German Registry until October 1997. One hundred and ninety-six patients fulfilled the criteria of the Behcet's disease classification tree. The prevalence of the disease evaluated in Berlin-West was 1.68/100,000 in 1989 and had risen to 2.26/100,000 by 1994. The median age of onset was 25 years (range 5 to 66 years; German-Turks, ns). Juvenile disease was recorded in 6.9% of patients. The complete clinical picture according to the criteria of the International Study Group of Behcet's Disease developed in 15.5 months. The interval between onset of the disease and diagnosis was 35 months, which was significantly longer than the duration of the development of the complete clinical picture (p < 0.0001). The disease was diagnosed later in German (48.5 months) than in Turkish patients (25.5 months, p = 0.003). While German patients presented an equal male-to-female ratio, a male predominance was shown in Turkish patients (M:F 2.1:1, p = 0.022). Familial occurrence was detected in 2.0% of German and 15.9% of Turkish patients (p = 0.013). The frequencies of major clinical manifestations were: oral ulcers 99%, skin lesions 76%, genital ulcers 75%, ocular manifestations 59%, arthritis 59%, and positive pathergy test 52%. Clinical differences between German and Turkish patients were only found in the frequency of ocular lesions (48% vs. 66%, p = 0.025). Oral ulcers were with 72% the most common onset symptom of the disease followed by erythema nodosum (9%), uveitis (7%), arthritis (7%), genital ulcers (3%), superficial thrombophlebitis (2%) and papules/sterile pustules (2%). Uveitis and erythema nodosum as onset symptoms shortened the median interval to diagnosis to 1.5 and 15 months, respectively, while arthritis delayed diagnosis (43.5 months; p = 0.029). A severe course developed in 25% of the patients; irreversible retinal vasculitis to blindness in 15%, sterile meningoencephalitis in 8%, severe arthritis in 5%, hemoptysis in 2%, lethal outcome in 2% and bowel perforation in 1%. The relative risk of HLA-B5 positive German natives developing the disease. HLA-B5 was confirmed as a marker of severe prognosis. Cardiolipin autoantibodies were associated with cutaneous vasculitis and superficial thrombophlebitis was correlated with systemic vessel involvement.

Keyword

Adamantiades-Behcet's disease; Behcet's disease; epidemiology; clinical picture; prognosis; Germany; Europe

MeSH Terms

Adolescence
Adult
Aged
Behcet's Syndrome/epidemiology*
Behcet's Syndrome/complications
Child
Child, Preschool
Europe/epidemiology
Female
Germany/epidemiology
Human
Male
Middle Age
Prognosis

Cited by  4 articles

Mucocutaneous Lesions of Behçet's Disease
Erkan Alpsoy, Christos Constantin Zouboulis, George Edward Ehrlich
Yonsei Med J. 2007;48(4):573-585.    doi: 10.3349/ymj.2007.48.4.573.

The Clinical Feature of Behçet's Disease in Northeastern China
Yingbin Shang, Shixin Han, Jiuhong Li, Qiushi Ren, Fangji Song, Hongduo Chen
Yonsei Med J. 2009;50(5):630-636.    doi: 10.3349/ymj.2009.50.5.630.

Serum Anti-Saccharomyces Cerevisiae Antibodies in Greek Patients with Behcet's Disease
George Vaiopoulos, Peter Laszlo Lakatos, Maria Papp, Faedon Kaklamanis, Efrosyni Economou, Vassilis Zevgolis, John Sourdis, Kostas Konstantopoulos
Yonsei Med J. 2011;52(2):347-350.    doi: 10.3349/ymj.2011.52.2.347.

Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study
Yasuo Suzuki, Takashi Hagiwara, Mariko Kobayashi, Kazuo Morita, Tomoyo Shimamoto, Toshifumi Hibi
Intest Res. 2021;19(3):301-312.    doi: 10.5217/ir.2020.00013.

Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr